Management of Severe Anti-Tumor Necrosis Factor (TNF) Induced Psoriasis in Patients with Inflammatory Bowel Disease

被引：1
|
作者：
Gold, Stephanie L. [1 ]
Cohen-Mekelburg, Shirley [1 ]
Schneider, Yecheskel [1 ]
Steinlauf, Adam [2 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-01732
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1732
引用
收藏
页码：S827 / S827
页数：1
相关论文
共 50 条
  • [21] Cutaneous manifestations of anti-tumor necrosis factor (anti-TNF) therapy in patients with inflammatory bowel disease (IBD): A case series
    Peer, F. C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 108 - 108
  • [22] Anti-tumor necrosis factor-α-induced psoriasis
    Sari, Ismail
    Akar, Servet
    Birlik, Merih
    Sis, Banu
    Onen, Fatos
    Akkoc, Nurullah
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1411 - 1414
  • [23] Should patients with inflammatory bowel disease and depression be given anti-tumor necrosis factor therapy?
    Barnes, A.
    Mountifield, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 130 - 130
  • [24] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Androulakis, Ioannis
    Zavos, Christos
    Christopoulos, Panagiotis
    Mastorakos, George
    Gazouli, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13205 - 13211
  • [25] Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
    Peter, Inga
    Dubinsky, Marla
    Bressman, Susan
    Park, Andrew
    Lu, Changyue
    Chen, Naijun
    Wang, Anthony
    JAMA NEUROLOGY, 2018, 75 (08) : 939 - 946
  • [26] Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
    Mahadevan, Uma
    Wolf, Douglas C.
    Dubinsky, Marla
    Cortot, Antoine
    Lee, Scott D.
    Siegel, Corey A.
    Ullman, Thomas
    Glover, Sarah
    Valentine, John F.
    Rubin, David T.
    Miller, Jocelyn
    Abreu, Maria T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (03) : 286 - 292
  • [27] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [28] Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
    Bortlik, Martin
    Duricova, Dana
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Malickova, Karin
    Kolar, Martin
    Lukas, Milan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (02) : 196 - 202
  • [29] The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease
    Koutroubakis, Ioannis E.
    Ramos-Rivers, Claudia
    Regueiro, Miguel
    Koutroumpakis, Efstratios
    Click, Benjamin
    Schwartz, Marc
    Swoger, Jason
    Baidoo, Leonard
    Hashash, Jana G.
    Barrie, Arthur
    Dunn, Michael A.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1587 - 1593
  • [30] Ustekinumab in the management of anti-tumor necrosis factor-induced psoriasiform lesions in inflammatory bowel disease: A systematic review
    Au, M.
    Chan, A.
    Smart, C.
    Philpott, H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 156 - 157
12345